SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-002156
Filing Date
2022-02-25
Accepted
2022-02-25 16:30:43
Documents
12
Period of Report
2022-02-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20220223x8k.htm   iXBRL 8-K 34470
  Complete submission text file 0001558370-22-002156.txt   154252

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpth-20220223.xsd EX-101.SCH 3078
3 EX-101.LAB bpth-20220223_lab.xml EX-101.LAB 16028
4 EX-101.PRE bpth-20220223_pre.xml EX-101.PRE 10228
6 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20220223x8k_htm.xml XML 4869
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 22680601
SIC: 2834 Pharmaceutical Preparations